CAREY STEPHEN P. 4

What Happened
Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals, had 5,150 shares withheld (disposed) to satisfy tax withholding obligations related to the vesting of restricted stock. The withheld shares were valued at $74.04 each, totaling approximately $381,306. The withholding relates to the vesting of 11,292 restricted shares previously granted; after withholding, Carey received a net 6,142 shares from that vesting.

Key Details

• Transaction date: 2026-03-07; share price used: $74.04.
• Shares withheld/disposed: 5,150; reported value: $381,306.
• Vesting involved: 11,292 restricted shares vested; 5,150 withheld for taxes → net 6,142 shares delivered.
• Footnote: withholding is exempt under Rule 16(b)-3 in connection with the previously reported restricted stock grant.
• Filing: Form 4 filed 2026-03-10 for the 3/7 transaction — appears timely (within the usual 2 business-day reporting window).
• Transaction code: F = tax withholding (not an open-market sale); no cash proceeds to the insider.

Context
This was a routine tax-withholding settlement tied to restricted stock vesting, not an active market sale or purchase. Such withholding transactions are standard and generally do not indicate the insider’s view on the company’s stock price.